Navigation Links
Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Fluctuations
Date:3/11/2009

Brooks Instrument, a world-leading flow measurement and control provider, is pleased to release the B-Series mass flow controller, a totally new family of mass flow products designed to be insensitive to fluctuations in pressure and temperature. Built on a standard 1.125-inch wide platform with a powerful user interface and local digital display, the B-Series provides a compact flow measurement and control solution which eliminates the need for costly temperature and pressure control devices and systems.

Hatfield, PA (PRWEB) March 11, 2009 -- Brooks Instrument, a world-leading flow measurement and control provider, is pleased to release the B-Series mass flow controller, a totally new family of mass flow products designed to be insensitive to fluctuations in pressure and temperature. Built on a standard 1.125-inch wide platform with a powerful user interface and local digital display, the B-Series provides a compact flow measurement and control solution which eliminates the need for costly temperature and pressure control devices and systems.

"The B-Series sets a new standard in gas mass flow control," stated Steve Kannengieszer, Director of Marketing, Mass Flow Products at Brooks Instrument. "Whether you are flowing gas to a CVD chamber, chemical research reactor, fuel cell test stand, or any other important flow control application, the quality of your results are only as good as the performance of your mass flow controller. The B-Series was designed to minimize all sources of gas flow inaccuracy, giving our customers outstanding accuracy, extremely fast response, exceptional stability, and robust resistance to flow variation due to pressure and temperature fluctuations."

Immune to Pressure and Temperature Fluctuations
The B-Series is a pressure- and temperature-insensitive device. The mass flow controller actively measures line pressure and adjusts the control valve to virtually eliminate actual flow and flow signal changes as a result of pressure fluctuations. In addition, the output of every B-Series mass flow controller is characterized over the full operating temperature range of the device allowing superior measurement and control accuracy regardless of process or ambient temperature conditions.

Unique Advanced Diagnostics
The B-Series incorporates sophisticated internal self-diagnostic routines that continuously check the health of the device. In the event of a diagnostic fault, an alarm code flashes on the user interface. An easy to use service port provides additional diagnostic capability, minimizing the need to remove the mass flow controller from process service.

Visit BrooksInstrument.com for more information about the Brooks B-Series mass flow controller.
   
About Brooks Instrument
Brooks Instrument is a world-leading flow measurement and control instrument provider, with headquarters in Hatfield, PA USA, and manufacturing locations, regional sales, and service offices in the Americas, Europe, and Asia. Brooks' products include glass and metal tube variable area meters (rotameters), thermal mass flow meters and controllers, Coriolis mass flow meters, controllers and transmitters, pressure control products, magnetic level instruments, and a variety of flow accessories. Since its founding in 1946, Brooks' products have supported the growth of dozens of industries from biopharmaceuticals, oil and gas, fuel cell research and chemicals, to medical devices, analytical instrumentation, semiconductor manufacturing, and more. Throughout the world, Brooks customers rely on a highly trained network of local representative specialists to help solve unique or unusual flow applications.   

Brooks is a mark owned by Brooks Instrument, LLC. All other marks are the property of their respective holders.

###

Read the full story at http://www.prweb.com/releases/BSeries/MassFlowController/prweb2219254.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. New Flexible Vacuum Controller from Varian, Inc. is Expandable and Easy to Use
2. Controllers Stem Cell Agency Audit Ignores California Agencys Built-in Flaws
3. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
4. Sopherion Therapeutics Secures $55 Million in Series C Funding
5. NanoBio Corporation Raises $12 Million in Series B Financing
6. Divergence Raises $11.8 Million in Series C Financing
7. Immune Targeting Systems Completes Second Tranche of Series-A Funding Bringing Total Funds Raised to More Than GBP5m
8. MODA Offers Paperless QC Micro Webinar Series on Automating Environmental Monitoring, Utility and Product Testing
9. TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing
10. Intradigm Closes Final Tranche of $21.4 Million Series B Financing
11. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Fluctuations 
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):